Business Description
Kezar Life Sciences Inc
NAICS : 325412
SIC : 2834
ISIN : US49372L1008
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 8.77 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | -0.18 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -14.4 | |||||
3-Year EPS without NRI Growth Rate | -11.4 | |||||
3-Year FCF Growth Rate | -10.9 | |||||
3-Year Book Growth Rate | -5.4 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49 | |||||
9-Day RSI | 40.43 | |||||
14-Day RSI | 39.25 | |||||
6-1 Month Momentum % | 15.38 | |||||
12-1 Month Momentum % | -11.35 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.65 | |||||
Quick Ratio | 7.65 | |||||
Cash Ratio | 7.26 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -16.2 | |||||
Shareholder Yield % | 6.28 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | -1090.97 | |||||
ROE % | -55.85 | |||||
ROA % | -47.24 | |||||
ROIC % | -466.76 | |||||
ROC (Joel Greenblatt) % | -1169.73 | |||||
ROCE % | -50.89 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.8 | |||||
PB Ratio | 0.36 | |||||
Price-to-Tangible-Book | 0.36 | |||||
EV-to-EBIT | 0.9 | |||||
EV-to-EBITDA | 0.91 | |||||
EV-to-Revenue | -12.07 | |||||
EV-to-FCF | 1.11 | |||||
Price-to-Net-Current-Asset-Value | 0.38 | |||||
Price-to-Net-Cash | 0.4 | |||||
Earnings Yield (Greenblatt) % | 111.11 | |||||
FCF Yield % | -159.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KZR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Kezar Life Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 7 | ||
EPS (TTM) ($) | -13.18 | ||
Beta | 0.56 | ||
Volatility % | 45.55 | ||
14-Day RSI | 39.25 | ||
14-Day ATR ($) | 0.30651 | ||
20-Day SMA ($) | 6.8595 | ||
12-1 Month Momentum % | -11.35 | ||
52-Week Range ($) | 5.202 - 11.35 | ||
Shares Outstanding (Mil) | 7.3 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Kezar Life Sciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Kezar Life Sciences Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Kezar Life Sciences Inc Frequently Asked Questions
What is Kezar Life Sciences Inc(KZR)'s stock price today?
When is next earnings date of Kezar Life Sciences Inc(KZR)?
Does Kezar Life Sciences Inc(KZR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |